Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 25, 2015 6:53 PM ET

Biotechnology

Company Overview of Gemini Genomics Limited

Company Overview

Gemini Genomics plc was acquired by Sequenom, Inc. on September 20, 2001. Gemini Genomics plc engaged as a clinical genomics company that uses clinical and medical information as a starting point to identify relationships between genes and human health and disease. The company's discoveries provided it with licensable products that pharmaceutical and diagnostic companies use in drug discovery and/or gene-based diagnostic applications.

162 Science Park Milton Road

Cambridge,  CB4 OGH

United Kingdom

126 Employees

Phone:

44 12 2343 5300

Key Executives for Gemini Genomics Limited

Gemini Genomics Limited does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Neurotex Limited Europe
BioSyntha Technology Ltd. Europe
EvoCell Ltd. Europe
Asterion Limited Europe
Immune Regulation Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Gemini Genomics Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.